Tianjin, China

Lingjun Li


 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Lingjun Li in Pharmaceutical Research

Introduction

Lingjun Li is a notable inventor based in Tianjin, China, recognized for his impactful contributions to pharmaceutical research. With one patent to his name, Li has made strides in the development of compounds that address critical medical challenges.

Latest Patents

Li's patent, titled "Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof," represents a significant advancement in the field. This invention provides a compound structured according to formula (I), along with its preparation method and uses. The compound is designed to enhance therapeutic efficacy while minimizing adverse effects related to current drugs. Specifically, it offers a solution to clopidogrel resistance and addresses severe hemorrhagic side effects, showcasing improved safety and stability compared to existing compounds. Additionally, it has the potential to develop into an ADP receptor antagonist antiplatelet agent with a clear therapeutic effect.

Career Highlights

Lingjun Li is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd., where he applies his expertise in drug development and innovation. His work is pivotal in creating pharmaceutical compositions that meet the evolving needs of healthcare.

Collaborations

In his professional journey, Li collaborates with esteemed colleagues, including Changjiang Huang and Shijun Zhang. Together, they contribute to advancing research and driving innovation within the pharmaceutical sector.

Conclusion

Through his innovative work and dedication to research, Lingjun Li stands out as a significant figure in the pharmaceutical field. His developments not only address critical issues in medication efficacy and safety but also set a precedent for future research in drug formulation and therapeutic applications. With ongoing contributions and collaborations, Li continues to impact healthcare positively, proving the importance of innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…